Literature DB >> 30543455

Club Cell Secretory Protein Deficiency Leads to Altered Lung Function.

Jing Zhai1, Michael Insel2, Kenneth J Addison2, Debra A Stern1, William Pederson2, Alane Dy2, Joselyn Rojas-Quintero3, Caroline A Owen3, Duane L Sherrill1, Wayne Morgan1, Anne L Wright1, Marilyn Halonen1, Fernando D Martinez1,4, Monica Kraft1,2, Stefano Guerra1,2,5, Julie G Ledford1,2,6.   

Abstract

RATIONALE: CC16 (club cell secretory protein-16), a member of the secretoglobin family, is one of the most abundant proteins in normal airway secretions and has been described as a serum biomarker for obstructive lung diseases.
OBJECTIVES: To determine whether low CC16 is a marker for airway pathology or is implicated in the pathophysiology of progressive airway damage in these conditions.
METHODS: Using human data from the birth cohort of the Tucson Children's Respiratory Study, we examined the relation of circulating CC16 levels with pulmonary function and responses to bronchial methacholine challenge from childhood up to age 32 years. In wild-type and CC16-/- mice, we set out to comprehensively examine pulmonary physiology, inflammation, and remodeling in the naive airway.
MEASUREMENTS AND MAIN RESULTS: We observed that Tucson Children's Respiratory Study participants in the lowest tertile of serum CC16 had significant deficits in their lung function and enhanced airway hyperresponsiveness to methacholine challenge from 11 years throughout young adult life. Similarly, CC16-/- mice had significant deficits in lung function and enhanced airway hyperresponsiveness to methacholine as compared with wild-type mice, which were independent of inflammation and mucin production. As compared with wild-type mice, CC16-/- mice had significantly elevated gene expression of procollagen type I, procollagen type III, and α-smooth muscle actin, areas of pronounced collagen deposition and significantly enhanced smooth muscle thickness.
CONCLUSIONS: Our findings support clinical observations by providing evidence that lack of CC16 in the lung results in dramatically altered pulmonary function and structural alterations consistent with enhanced remodeling.

Entities:  

Keywords:  CC16; CCSP; COPD; asthma; uteroglobin

Mesh:

Substances:

Year:  2019        PMID: 30543455      PMCID: PMC6363971          DOI: 10.1164/rccm.201807-1345OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  55 in total

1.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.

Authors:  R Ross; J Glomset; B Kariya; L Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

2.  Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectin.

Authors:  Giovanni Antico; Mark W Lingen; Antonella Sassano; James Melby; Richard W Welch; Stefano Fiore; Aprile L Pilon; Lucio Miele
Journal:  J Cell Physiol       Date:  2006-05       Impact factor: 6.384

3.  A novel nonhuman primate model of cigarette smoke-induced airway disease.

Authors:  Francesca Polverino; Melanie Doyle-Eisele; Jacob McDonald; Julie A Wilder; Christopher Royer; Maria Laucho-Contreras; Emer M Kelly; Miguel Divo; Victor Pinto-Plata; Joe Mauderly; Bartolome R Celli; Yohannes Tesfaigzi; Caroline A Owen
Journal:  Am J Pathol       Date:  2014-12-24       Impact factor: 4.307

4.  The Tucson Children's Respiratory Study. I. Design and implementation of a prospective study of acute and chronic respiratory illness in children.

Authors:  L M Taussig; A L Wright; W J Morgan; H R Harrison; C G Ray
Journal:  Am J Epidemiol       Date:  1989-06       Impact factor: 4.897

5.  Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort.

Authors:  D A Lomas; E K Silverman; L D Edwards; B E Miller; H O Coxson; R Tal-Singer
Journal:  Thorax       Date:  2008-08-29       Impact factor: 9.139

6.  Assessment of airway hyperresponsiveness in mouse models of allergic lung disease using detailed measurements of respiratory mechanics.

Authors:  John M Hartney; Annette Robichaud
Journal:  Methods Mol Biol       Date:  2013

7.  Protein 1 (Clara cell protein) serum levels in healthy subjects and patients with bacterial pneumonia.

Authors:  H Nomori; H Horio; G Fuyuno; R Kobayashi; S Morinaga; Y Hirabayashi
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

8.  Club cell secretory protein in serum and bronchoalveolar lavage of patients with asthma.

Authors:  Stefano Guerra; Monica M Vasquez; Amber Spangenberg; Marilyn Halonen; Richard J Martin
Journal:  J Allergy Clin Immunol       Date:  2016-05-11       Impact factor: 10.793

9.  Combined forced oscillation and forced expiration measurements in mice for the assessment of airway hyperresponsiveness.

Authors:  Karim H Shalaby; Leslie G Gold; Thomas F Schuessler; James G Martin; Annette Robichaud
Journal:  Respir Res       Date:  2010-06-21

10.  Repression of CC16 by cigarette smoke (CS) exposure.

Authors:  Lingxiang Zhu; Peter Y P Di; Reen Wu; Kent E Pinkerton; Yin Chen
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

View more
  17 in total

1.  Taking Precise Aim at Lung Disease.

Authors:  Giovanni Piedimonte
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

2.  CC16 Levels into Adult Life Are Associated with Nitrogen Dioxide Exposure at Birth.

Authors:  Paloma I Beamer; Melissa Furlong; Nathan Lothrop; Stefano Guerra; Dean Billheimer; Debra A Stern; Jing Zhai; Marilyn Halonen; Anne L Wright; Fernando D Martinez
Journal:  Am J Respir Crit Care Med       Date:  2019-09-01       Impact factor: 21.405

3.  Lung developmental is altered after inhalation exposure to various concentrations of calcium arsenate.

Authors:  Binh Chau; Mark L Witten; Doug Cromey; Yin Chen; R Clark Lantz
Journal:  Toxicol Appl Pharmacol       Date:  2021-10-09       Impact factor: 4.219

4.  Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.

Authors:  Mai Sasaki Aanensen Fraz; Annika Elisabet Michelsen; Natasha Moe; Trond Mogens Aaløkken; Magnhild Eide Macpherson; Ingvild Nordøy; Pål Aukrust; Eli Taraldsrud; Are Martin Holm; Thor Ueland; Silje Fjellgård Jørgensen; Børre Fevang
Journal:  J Clin Immunol       Date:  2022-07-05       Impact factor: 8.542

Review 5.  Emerging role of an immunomodulatory protein secretoglobin 3A2 in human diseases.

Authors:  Shioko Kimura; Shigetoshi Yokoyama; Aprile L Pilon; Reiko Kurotani
Journal:  Pharmacol Ther       Date:  2022-01-10       Impact factor: 13.400

6.  CC16 Deficiency in the Context of Early-Life Mycoplasma pneumoniae Infection Results in Augmented Airway Responses in Adult Mice.

Authors:  Natalie Iannuzo; Michael Insel; Craig Marshall; William P Pederson; Kenneth J Addison; Francesca Polverino; Stefano Guerra; Julie G Ledford
Journal:  Infect Immun       Date:  2021-11-15       Impact factor: 3.609

7.  An Elusive Fox that Suppresses Scgb1a1 in Asthma Has Been Found.

Authors:  Rachel Warren; Michael A O'Reilly
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

8.  CC16: A Biomarker of Pollutant Exposure and Future Lung Disease?

Authors:  Ingrid A Laing
Journal:  Am J Respir Crit Care Med       Date:  2019-09-01       Impact factor: 21.405

9.  Gestational Exposure to Cigarette Smoke Suppresses the Gasotransmitter H2S Biogenesis and the Effects Are Transmitted Transgenerationally.

Authors:  Shashi P Singh; Dinesh Devadoss; Marko Manevski; Aryaz Sheybani; Teodora Ivanciuc; Vernat Exil; Hemant Agarwal; Veena Raizada; Roberto P Garofalo; Hitendra S Chand; Mohan L Sopori
Journal:  Front Immunol       Date:  2020-07-28       Impact factor: 7.561

Review 10.  Airway Remodeling in Asthma.

Authors:  Kenneth P Hough; Miranda L Curtiss; Trevor J Blain; Rui-Ming Liu; Jennifer Trevor; Jessy S Deshane; Victor J Thannickal
Journal:  Front Med (Lausanne)       Date:  2020-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.